Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000491921 | SCV000580038 | pathogenic | Hereditary cancer-predisposing syndrome | 2014-06-09 | criteria provided, single submitter | clinical testing | The c.757dupA pathogenic mutation, located in coding exon 7 of the PTEN gene, results from a duplication of A at position 757, causing a translational frameshift with a predicted alternate stop codon. This mutation was identified in an individual who had PTEN clinical testing due to clinical suspicion of PTEN hamartoma tumor syndrome (PHTS) (Pilarski, R et al. J Med Genet. 2011 Aug;48(8):505-12). In addition to the clinical data presented in the literature, since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). |